Company News, Industry News

Nestle Expands Skin Health Platform

To purchase key assets of Valeant Pharmaceutical for $1.4 billion.

Author Image

By: TOM BRANNA

Editor

Looks like Nestlé is serious about skin health. Today, the company said it will reinforce its newly-created Nestlé Skin Health unit with the the full rights to commercialize several key aesthetic dermatology products from Valeant Pharmaceuticals International. The $1.4 billion cash deal is for the US and Canada. The two markets together represent more than half of the fast-growing medical aesthetics market around the world. Galderma already commercialises the products included in this transactio...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters